True Leaf Schedules Annual Earnings Conference Call and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
163
True Leaf Schedules Annual Earnings Conference Call and Business Update

Conference call to take place Wednesday, July 11, 2018 at 5:00pm ET

Investors encouraged to submit all questions for Q&A by Monday, July 9, 2018

VERNON, British Columbia, July 05, 2018 (GLOBE NEWSWIRE) -- True Leaf Medicine International Ltd. (“ True Leaf ”) (CSE:MJ) (OTCQB:TRLFF) (FSE:TLA), a plant-forward wellness brand for people and their pets, will host a conference call to discuss its fiscal year 2018 financial results first announced on June 28, 2018.

True Leaf Founder and Chief Executive Officer, Darcy Bomford, will host the call on Wednesday, July 11, and provide an update on recent developments, including details on revenue growth fueled by the expanding True Leaf Pet division and the construction of True Leaf Campus, the company’s cannabis cultivation and production facility.

Immediately following True Leaf’s remarks during the Earnings Conference Call on July 11, management will host a Question-and-Answer (Q&A) session to address shareholder concerns. True Leaf invites all investors, media, and interested parties to submit any questions they would like to hear answered by management to  ir@trueleaf.com or to True Leaf’s Investor Relations’ advisor at  tpatel@edisongroup.com . Please submit all questions for the Q&A session no later than Monday, July 9, 2018.

Additionally, the company will take questions by email during the conference call and we will respond to as many of the questions as we can in the time allowed.

To participate in the call, please dial 1-877-407-0312 (toll-free) in the U.S. and Canada, or 1-201-389-0899 (toll). The conference ID number for both is 13681284. Participants can also listen to the call via the live webcast at the link below.

Event: FY 2018 Earnings and Business Update Conference Call
Date: Wednesday, July 11, 2018
Time: 2:00pm Pacific Time, 5:00pm Eastern Time
U.S. & Canada Dial-in: 1-877-407-0312 (toll free)
U.S. & Canada Dial-in: 1-201-389-0899 (toll)
Conference ID: 13681284
Webcast Link: https://webcasts.eqs.com/trueleaf20180711

A live audio webcast of the conference call will also be available on the investor relations page of True Leaf’s corporate website at www.trueleaf.com .

About True Leaf

True Leaf is a plant-forward wellness brand for people and their pets. Founded in 2013, True Leaf has two main operating divisions: True Leaf Medicine Inc. and True Leaf Pet Inc.

True Leaf Medicine Inc. is in the final stages of approval to become a licensed producer of federally-approved medicinal cannabis for the Canadian market. The license is subject to a Health Canada inspection to allow for the production, manufacture, and distribution of cannabis products upon the completion of True Leaf Campus: the company’s cannabis cultivation facility being built in Lumby, British Columbia. Construction is expected to be completed in fall 2018.

Established in 2015, True Leaf Pet Inc. is one of the first companies to market hemp-based products for pets worldwide. The company is initially marketing a line of hemp-seed based supplements for pets. True Hemp™ chews, dental sticks, and supplement oils are sold in more than 1,800 stores across North America and Europe.

www.trueleaf.com

Media Contact:

Paul Sullivan Director, Public Relations Paul@trueleaf.com O: 604-685-4742 M: 604-603-7358

Investor Contact:

Kevin Bottomley (Canada) Director and Corporate Relations Kevin@trueleaf.com M: 778-389-9933

Tirth Patel (US) Edison Advisors tpatel@edisongroup.com O: 646-653-7035    Follow True Leaf

twitter.com/trueleafpet

facebook.com/trueleafpet

instagram.com/trueleafpet

Forward-Looking Statements

This news release contains forward-looking statements and management may make additional forward-looking statements in response to your questions. Such written and oral disclosures are made pursuant to the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995 and True Leaf hereby claims such safe harbour protection for all forward-looking statements. True Leaf believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions; however, True Leaf’s actual results and performance and the value of its securities could differ materially from those set forth in the forward-looking statements due to the impact of many factors summarized in the "Risk Factors" section of True Leaf’s Offering Circular Form 1-A filed with the U.S. Securities and Exchange Commission and Canadian securities regulatory authorities and other discussions of risk factors contained in True Leaf’s periodic filings or supplements to the offering circular. True Leaf's Offering Circular Form 1-A can be found at www.trueleaf.com/pages/investor . Forward-looking statements speak only as of the date they are made. True Leaf undertakes no obligation to update or revise any such information for any reason after the date of this presentation unless required by law.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 129

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 42

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 241

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 343

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading

Top 5 Most Recently Viewed Articles

Anticipating NeuroOne's Q2 Financial Insights and Growth Strategies

Updated Category News Views 124

NeuroOne Prepares to Release Second Quarter Fiscal Financial Results EDEN PRAIRIE, Minn. — NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) is set to unveil its financial performance for the fiscal second quarter. The reporting period ended on March 31, and the results will be publicized before market activities commence on May 13. This is an exciting time for...

Continue Reading
FNB's Grand Plan for Ultra-Rich Wealth Clients

Updated Category News Views 79

FNB Corporation's New Strategy Sparks Interest Ah, the ever-competitive world of financial services targets the well-heeled once again. FNB Corporation (NYSE: FNB), headquartered in Pittsburgh, is rolling up its sleeves to offer something new for ultra-high-net-worth clientele. Outside Wall Street's dizzying chaos, this quiet yet aggressive move seems to signal they're up...

Continue Reading
Brazil Stock Market Trends and Key Indicators Update

Updated Category News Views 300

Brazil Stock Market Overview Recently, Brazil's stock market showed signs of decline, particularly on a Thursday when the Bovespa index dropped by 0.79%, reaching a new three-month low. This downturn was primarily driven by losses in critical sectors such as Public Utilities, Electric Power, and Real Estate. Investors and market analysts closely monitor these trends as...

Continue Reading
NEXN Stock Reaches New Heights Amid Positive Market Trends

Updated Category News Views 159

NEXN Stock Hits New Milestone NEXN stock has recently hit a significant milestone, reaching a price of $8.34. This impressive peak is not just a reflection of the company’s strong performance but also highlights a period filled with optimism in the market. With investors closely monitoring the stock's path, this new high may point to a potential sustained upward trend...

Continue Reading
Total Voting Rights Update from PayPoint Plc

Updated Category News Views 108

Understanding PayPoint Plc's Total Voting Rights PayPoint Plc has recently provided an update regarding its voting rights and share capital, which is crucial information for shareholders and those interested in the company. Total Share Capital Information As of August 31, 2024, PayPoint Plc's share capital consists of 72,342,171 ordinary shares, each valued at 1/3 pence....

Continue Reading